环孢素治疗伴有8号染色体三体骨髓增生异常综合征的疗效分析
Efficacy analysis of cyclosporine in treatment of trisomy 8 myelodysplastic syndrome
摘要
骨髓增生异常综合征(MDS)是一类异质性造血干细胞克隆性疾病,其治疗策略主要依据国际预后积分系统(IPSS),结合患者年龄、体能状况、疾病进展程度等因素评价。对于大多数病程平稳、以难治性血细胞减少为主要表现的中低危MDS患者,治疗常以升高患者血细胞计数和改善患者生活质量为主。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2014年第1期61-62,共2页
Chinese Journal of Hematology
基金
国家自然科学基金(81000921)
参考文献8
-
1Valent P,Horny HP,Bennett JM. Def'mitions and standards in the diagnosis and treatment of the myelodysplastic syndromes:Consensus statements and report from a working conference[J].Leukemia Research,2007,(06):727-736.
-
2Cheson BD,Greenberg PL,Bennett JM. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia[J].Blood,2006,(02):419-425.
-
3邱镜滢,赖悦云,柴晔,张艳,师岩,何琦,党辉,陆道培.306例骨髓增生异常综合征染色体核型的研究[J].中国实验血液学杂志,2004,12(4):455-459. 被引量:32
-
4曲士强,刘旭平,徐泽锋,张悦,秦铁军,张天佼,崔蕊,郝玉书,肖志坚.不同细胞遗传学预后分组对原发性骨髓增生异常综合征患者预后意义的研究[J].中华血液学杂志,2011,32(12):819-824. 被引量:13
-
5Chen G,Zeng W,Miyazato A. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities[J].Blood,2004,(13):4210-4218.
-
6Sloand EM,Kim S,Fuhrer M. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8hematopoietic cells but not in cells with other cytogenetic abnormalities[J].Blood,2002,(13):4427-4432.
-
7Sloand EM,Mainwaring L,Fuhrer M. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphoeytes in patients with trisomy 8 myelodysplastic syndrome[J].Blood,2005,(03):841-851.
-
8Galili N,Cemy J,Raza A. Current treatment options:impact of cytogenetics on the course of myelodysplasia[J].Current Treatment Options in Oncology,2007,(02):117-128.
二级参考文献15
-
1薛永权.伴有8;21染色体易位的骨髓增生异常综合征的新评价[J].国外医学(输血及血液学分册),1997,20(2):105-107. 被引量:1
-
2Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 1997, 89:2079-2088.
-
3Haase D, Germing U, Schanz J, et al. New insights into the prog- nostic impact of the karyotype in MDS and correlation with sub- types: evidence from a core dataset of 2124 patients. Blood, 2007, 110: 4385-4395.
-
4Schanz J, Tuchler H, Sole F, et al. Proposal of a new, compre- hensive cytogenetic scoring system for primary MDS. Haematologi- ca, 2010, 95 Suppl 2: Abstract 535.
-
5Greenberg P, Tuechler H, Schanz J, et al. Revised International Prognostic Scoring System ( IPSS-R), developed by the Interna- tional Prognostic Working Group for Prognosis in MDS ( IWG- PM). Leuk Res, 2011, 35 Suppl 1: Abstract 14.
-
6Chun K, Hagemeijer A, Iqbal A, et al. Implementation of stand- ardized international karyotype scoring practices is needed to pro- vide uniform and systematic evaluation for patients with myelodys- plastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study. Leuk Res, 2010, 34: 160- 165.
-
7Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the rnyelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res, 2007, 31 : 727-736.
-
8Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol, 2008, 87: 515-526.
-
9Schanz J, Steidl C, Fonatsch C, et al. Coalesced muhicentric analysis of 2,351 patients with myelodysplastic syndromes indi- cates an underestimation of poor-risk cytogenetics of myelodysplas- tic syndromes in the International Prognostic Scoring System. J Clin Oncol, 2011,29 : 1963-1970.
-
10Sole F, Luno E, Sanzo C, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica, 2005, 90: 1168-1178.
共引文献42
-
1朱伟,张加强,郭玉琳,张鲁勤.巨幼细胞性贫血误诊为骨髓增生异常综合征[J].临床误诊误治,2005,18(5):307-308. 被引量:4
-
2李云.骨髓增生异常综合征65例骨髓涂片检查结果分析[J].中国煤炭工业医学杂志,2005,8(6):577-578.
-
3张伟,徐三男,陈万新.巨幼细胞性贫血32例临床分析[J].临床内科杂志,2006,23(8):565-565. 被引量:8
-
4王化泉,邵宗鸿,邢莉民,付蓉,施均,曹燕然,刘鸿,白洁,涂梅峰,孙娟.单纯+8染色体改变的骨髓增生异常综合征24例分析[J].中华内科杂志,2007,46(5):399-400.
-
5罗云,张萍,娄世锋.苯中毒致染色体复杂核型异常1例并文献复习[J].重庆医科大学学报,2007,32(10):1099-1100.
-
6黄伟萍.巨幼贫伴再障误诊为原始细胞过多性难治性贫血21例分析[J].实验与检验医学,2008,26(2):178-178.
-
7骨髓增生异常综合征435例WHO分型和细胞遗传学分析[J].中华内科杂志,2008,47(6):464-467. 被引量:10
-
8秦玲,王椿,秦尤文,谢匡成,颜式可,高彦荣,王小蕊,赵初娴.骨髓增生异常综合征del(20q)异常细胞克隆在骨髓细胞系列和凋亡细胞中的分布[J].中国实验血液学杂志,2008,16(3):551-554. 被引量:3
-
9张淑英,姜丽波,周虹,韩树林,曲延章,郭珩,王苏亮.骨髓增生异常综合征染色体核型变化与预后相关性的临床研究[J].白血病.淋巴瘤,2008,17(4):296-297. 被引量:2
-
10许晓倩,王健民,吕书晴,陈莉,杨建民,章卫平,宋献民,许燕群,龚胜蓝,侯军,倪雄.80例骨髓增生异常综合征患者预后因素分析[J].中华血液学杂志,2008,29(11):723-727. 被引量:8
-
1薛永权,过宇.8号染色体三体与血液病[J].中华血液学杂志,1991,12(6):301-304.
-
2徐冉行,吴建国.骨髓增生异常综合征染色体核型分析[J].浙江预防医学,2006,18(5):67-67. 被引量:2
-
3唐松均.维甲酸结合小剂量化疗治疗骨髓增生异常综合征的疗效分析(附6例报告)[J].苏州医学杂志,1994,17(4):17-18.
-
4吴明正,周泽平,文静,顾雪萍,胡兰,陈安宝.原发性血小板增多症的危险分层与治疗进展[J].实用医学杂志,2015,31(17):2920-2921. 被引量:9
-
5曹海武.沙利度胺联合阿糖胞苷治疗骨髓增生异常综合征的疗效观察[J].中外医学研究,2011,9(10):84-84. 被引量:4
-
6李长荣,王冰.老年人骨髓增生异常综合征26例分析[J].中国实用医药,2006,1(3):78-79.
-
7武英伟,孙玉静,张茉莉,华正祥,郭玉峰,张秀琴.单纯8号染色体三体异常的骨髓增生异常综合征19例分析[J].广东医学,2013,34(2):268-270. 被引量:2
-
8郑冬丽.68例骨髓增生异常综合征临床诊治分析[J].中国医药导报,2010,7(25):157-158. 被引量:1
-
9李亮亮,柴晔,张连生.微小RNA在骨髓增生异常综合征中的异常表达及临床意义[J].中华医学杂志,2013,93(28):2253-2256.
-
10张俊,薛永权,潘金兰,吴亚芳,王勇,沈娟,仇惠英.一例伴有t(1;7)和8号染色体三体异常而无病态造血改变的骨髓增生异常综合征[J].中华血液学杂志,2007,28(6):418-419. 被引量:2